Submissions
1
Thalidomide Group Australia
3
Department of Social Services
4
UK Thalidomide Campaigns Team
5
Professor Richard Madden
31
NESOS Board of Dutch Thalidomide survivors
53
Interessenverband Contergangeschädigter Nordrhein-Westfalen e.V. and International Contergan / Thalidomide Alliance
59
Thalidomide Victims Association of Canada
61
UK Thalidomide Society
62
Professor Neil Vargesson
67
Professor Janet McCredie
Additional Information
1
Journal article: The changing health of Thalidomide survivors as they age: A scoping review, E. Newbronner, K. Atkin and D. Phil, from Thalidomide Group Australia, received 1 October 2018
2
Report: Study on the current living conditions of Canadian thalidomide survivors and their projections for their future, Thalidomide Victims Association of Canada, from Thalidomide Group Australia, received 1 October 2018
3
Rebuttal to Department of Health's answers to questions on notice from Melbourne public hearing, from Thalidomide Group Australia, received 8 January 2019
4
Further information following appearance at Sydney public hearing, from Professor Neil Vargesson, received 1 February 2019
5
Response to comments from Thalidomide Group Australia regarding Department of Health's answers to questions on notice, from Department of Health, received 6 February 2019
6
Further information following appearance at Sydney public hearing, from Professor Neil Vargesson, received 6 February 2019
7
Further information, from Professor Janet McCredie, received 11 February 2019
8
Article: Maggie De Block keeps her word: sixty years later, 5 million euros for the victims of Softenon, from Thalidomide Group Australia, received 14 February 2019
9
Information relating to the 2010 Diageo assessment process, from Mr Peter Semmler QC, received 27 February 2019
Answer to Question on Notice
1
Answers to Questions taken on Notice during 2 November public hearing, received from Thalidomide Group Australia, 20 November 2018
2
Answers to Questions taken on Notice during 2 November public hearing, received from Department of Social Services, 27 November 2018
3
Answers to Questions taken on Notice during 2 November public hearing, received from Department of Health, 27 November 2018
4
Answers to written Questions on Notice, received from Thalidomide Group Australia, 24 January 2019
5
Answers to written Questions on Notice, received from Australian College of Rural and Remote Medicine, 25 January 2019
6
Answers to written Questions on Notice, received from National Disability Insurance Agency, 29 January 2019
7
Answers to written Questions on Notice, received from Northern Territory Government, 30 January 2019
8
Answers to written Questions on Notice, received from Department of Health, 31 January 2019
9
Answers to written Questions on Notice, received from Royal Australian College of General Practitioners, 1 February 2019
10
Answers to written Questions on Notice, received from Queensland Government, 1 February 2019
11
Answers to written Questions on Notice, received from Tasmanian Government, 5 February 2019
12
Answers to written Questions on Notice, received from ACT Government, 15 February 2019
13
Answers to written Questions on Notice, received from NSW Government, 21 February 2019
14
Answers to written Questions on Notice, received from WA Government, 26 February 2019
15
Answers to Questions taken on Notice during 31 January public hearing, received from Thalidomide Australia Fixed Trust, 7 February 2019
16
Answers to Questions taken on Notice during 31 January public hearing, received from National Disability Insurance Agency, 7 February 2019
17
Answers to Questions taken on Notice during 31 January public hearing, received from Department of Health, 22 February 2019
18
Answers to written Questions on Notice, received from Mr Peter Semmler QC, 27 February 2019
19
Answers to written Questions on Notice, received from Health Canada, 28 February 2019
20
Answers to written Questions on Notice, received from Gordon Legal, 1 March 2019
21
Answers to written Questions on Notice, received from Diageo, 1 March 2019
22
Answers to written Questions on Notice, received from Department of Human Services, 6 March 2019
23
Answers to written Questions on Notice, received from Department of Finance, 6 March 2019
24
Answers to written Questions on Notice, received from National Disability Insurance Agency, 7 March 2019
25
Answers to written Questions on Notice, received from Department of Veterans’ Affairs, 8 March 2019
26
Answers to written Questions on Notice, received from Australian Taxation Office, 12 March 2019
27
Answers to written Questions on Notice, received from Department of Social Services, 13 March 2019
Correspondence
1
Letter from private individual, received 13 October 2018
2
Letter from private individual, received 12 October 2018
3
Letter from private individual, received 11 October 2018
4
Letter from private individual, received 10 October 2018
5
Letter from private individual, received 9 October 2018
6
Letter from private individual, received 9 October 2018
7
Letter from private individual, received 8 October 2018
8
Letter from private individual, received 8 October 2018
9
Letter from private individual, received 8 October 2018
10
Letter from private individual, received 8 October 2018
11
Letter from private individual, received 10 October 2018
12
Letter from private individual, received 14 September 2018
13
Letter from private individual, received 11 October 2018
14
Letter from private individual, received 23 October 2018
15
Letter from private individual, received 21 October 2018
16
Correspondence clarifying statements made at Melbourne public hearing on 2 November 2018, received from Thalidomide Group Australia, 20 November 2018
17
Letter from Minister for Communities and Minister for Disability Services and Seniors to Chair of the Community Affairs References Committee, dated 22 January 2019; and letter from Premier of Queensland to Prime Minister of Australia, dated 2 September 2015, received from Queensland Government, 22 January 2019
18
Response to conclusions and recommendations contained in the interim report, received from Department of Human Services, 8 March 2019
19
Response to conclusions and recommendations contained in the interim report, received from Department of Health, 12 March 2019
20
Response to conclusions and recommendations contained in the interim report, received from Royal Australian College of Physicians, 12 March 2019
21
Correspondence clarifying the role of the Trust, received from Thalidomide Australia Fixed Trust, 19 March 2019
22
Response to conclusions and recommendations contained in the interim report, received from Department of Social Services, 22 March 2019
Tabled Documents
1
Historical recommendations by Governments, Royal Commissions and National Health & Medical Research Councils to prevent toxic and damaging pharmaceutical drugs entering Australia, tabled by Brett, at Sydney public hearing, 31 January 2019